Equity Overview
Price & Market Data
Price: $10.30
Daily Change: -$0.28 / 2.72%
Daily Range: $9.95 - $10.64
Market Cap: $125,802,144
Daily Volume: 127,288
Performance Metrics
1 Week: 3.21%
1 Month: -17.47%
3 Months: 66.40%
6 Months: -31.33%
1 Year: -17.67%
YTD: -54.65%
Company Details
Employees: 14
Sector: Health technology
Industry: Biotechnology
Country:
Details
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.